4 December 2023Dr Michelle Tempest, Senior Partner at Candesic, featured in the Financial Times discussing the implications of increased reliance of the NHS on private providers. Private sector…- 28 November 2023Candesic Senior Partner Dr Michelle Tempest discusses in Healthcare Business International the constraints for the NHS to deliver on its targets. The financial pressure on the NHS makes outsourcing…
- 18 November 2023By 2030, the 50-plus population is projected to be a significant driver of consumer growth in the longevity market, representing…
- 6 November 2023Candesic Senior Partner Dr Michelle Tempest contributed her perspective to The Guardian on Daye’s innovative STI diagnostic tampon which allows convenient testing at-home. The British start-up's innovative…
- 2 November 2023HealthInvestor features Dr Michelle Tempest, Senior Partner at Candesic, commenting on the government’s AI Life Sciences Accelerator Mission £100 million fund. The fund will…
- 1 November 2023Government initiatives such as the £100m investment programme to accelerate use of AI in life sciences, and the AI Safety…
- 24 October 2023Senior partner at Candesic Dr Michelle Tempest shared in the Financial Times her views on the complex dynamics currently affecting the UK’s private healthcare sector. The recent…
- 23 October 2023Dr Leonid Shapiro, managing partner at Candesic, and Dr Joe Taylor, principal at Candesic, examine the phenomenon of synthetic human…
11 October 2023andesic team, Dr Michelle Tempest and Juliet Frances Thornton in the new LaingBuisson HealthcareMarkets UK investigate the opportunities of electronic…- 21 September 2023We are thrilled to introduce to you our Business Analyst class of 2023. Let`s welcome Jawad Barbar, Campbell Foubister, Zeynep…
